US, Canada, Bahrain Impose Entry Bans as Bundibugyo Ebola Outbreak Spreads

The Democratic Republic of the Congo is in the grip of its worst Ebola outbreak on record, and the world is responding with the kind of blunt force that comes when there are no good options left. The culprit is the Bundibugyo virus, a rare strain that does not respond to the vaccines developed for the more common Zaire variant. With over 2,500 confirmed cases and more than 1,000 deaths, the outbreak has metastasized from a regional crisis into a global containment problem that is rewriting travel rules, grounding aircraft, and collapsing insurance markets across three continents.

The speed and scale are what distinguish this moment. The epicenter sits in Ituri Province, where more than 90 percent of infections have been documented, but the virus has already reached neighboring provinces and crossed into Uganda, where twenty cases and two deaths have been recorded. The World Health Organization and national governments have declared this a Public Health Emergency of International Concern. What makes that designation more than ceremonial is what follows: the hard choices about who can move and where.

The United States has barred non-citizens who have visited the Democratic Republic of the Congo, Uganda, or South Sudan within the previous twenty-one days from entering the country. In mid-July, the Centers for Disease Control expanded that ban to include green card holders—a significant escalation that caught even some permanent residents off guard. Canada took a different route, freezing the processing of all temporary and permanent resident visas for applicants from those three countries and prohibiting anyone who has been in the DRC within the past three weeks from boarding flights to Canadian soil. Bahrain imposed a thirty-day lookback period with similar effect. The message was consistent across borders: if you have been there, you cannot come here.

For American citizens trying to return home, the restrictions are more granular but no less disruptive. The government has designated exactly three airports as legal entry points for anyone arriving from the affected regions: Washington Dulles, Hartsfield-Jackson Atlanta, and George Bush Intercontinental in Houston. These hubs have been equipped with specialized public health personnel and medical assessment facilities. Any returning citizen attempting to land elsewhere must reroute their journey. It is a blunt instrument, but it concentrates screening capacity where it can actually function.

The aviation industry is absorbing the shock in real time. KLM cancelled its flights to Entebbe, Uganda, because the risk calculus had shifted: crews flying into Uganda would become ineligible to enter other destinations due to the entry bans, making the route economically unviable. Brussels Airlines implemented a new protocol prohibiting personnel assigned to flights into Uganda or the DRC from being scheduled for subsequent flights to the United States. The airline industry is essentially policing itself to stay compliant with border health requirements. These are not abstract operational adjustments—they represent canceled routes, rescheduled crews, and the slow strangulation of air connectivity to an entire region.

The ground-level consequences are equally severe. Border crossings between the DRC and Uganda have slowed dramatically, choking off not just commuter traffic but also commercial freight and humanitarian aid delivery at a moment when both are desperately needed. The travel insurance market has effectively ceased to function in the region. Because the U.S. State Department has issued a Level 4 "Do Not Travel" advisory for Uganda and specific DRC provinces, most international insurers have suspended or invalidated coverage. Business travelers and nongovernmental organizations are canceling missions not because of the virus itself but because they cannot obtain medical and liability protection.

The medical reality underlying all of this is stark. There is no licensed vaccine for the Bundibugyo strain. The Africa CDC and WHO are running clinical trials on Remdesivir and a monoclonal antibody therapy called MBP134, but these are still experimental. Containment is further hampered by the fact that eastern DRC is unstable, with armed militia activity disrupting contact tracing and overwhelming local isolation facilities. Health workers cannot operate safely. Public trust has eroded. Two high-profile medical evacuations—one doctor to France in June, one U.S. humanitarian worker to Germany in mid-July—underscore both the severity of infection and the international resources being mobilized to save lives when they can be reached.

The DRC Health Ministry has imposed strict outbound travel controls on health professionals and laboratory staff working at the outbreak's center, requiring a mandatory twenty-one-day isolation and monitoring period before departure. Ten neighboring countries, including Kenya, Tanzania, Rwanda, Burundi, and South Sudan, have strengthened border screenings. The global aviation network remains on high alert. What began as a regional health emergency has become a logistical and economic crisis that will reshape how people and goods move through Central Africa for months to come.